Hmmm. The FDA "action" to Eli Lily was a notification in November 2019. I don't see how it is meaningful today since a lot of proverbial "water" has gone over the top of the dam since then. Key words in the article make it sound like a never-Trump posting instead of real news. Just as a point of reference, I saw a similar, though far worse FDA notification sent to IMMU in the form of a "complete response letter" in January 2019. The letter knocked its share price into the lower teens. Of course, we know that slightly more than a year and a half later, IMMU has been bought by Gilead for $88. At this point in time, I would not buy or sell Lily stock nor would I be intimidated by so-called news of this sort that has all the appearances of being just a political hit piece.